Amato J. Giaccia,Erinn Bruno Rankin,Jennifer R. Cochran,Douglas Jones,Mihalis Kariolis,Katherine Cynthia Fuh,Yu Miao,Susan Hershenson
申请号：
US15783850
公开号：
US20180030422A1
申请日:
2017.10.13
申请国别(地区):
US
年份:
2018
代理人:
摘要：
Compositions and methods are provided for alleviating cancer in a mammal by administering a therapeutic dose of a pharmaceutical composition that inhibits activity of AXL, MER or Tyro3 protein activity, for example by competitive or non-competitive inhibition of the binding interaction between AXL, MER or Tyro3 and its ligand GAS6.
